Defender Capital, LLC. - STAAR SURGICAL CO ownership

STAAR SURGICAL CO's ticker is STAA and the CUSIP is 852312305. A total of 299 filers reported holding STAAR SURGICAL CO in Q3 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.

Quarter-by-quarter ownership
Defender Capital, LLC. ownership history of STAAR SURGICAL CO
ValueSharesWeighting
Q3 2023$21,833,691
-19.7%
543,397
+5.0%
7.90%
-15.5%
Q2 2023$27,197,159
-13.5%
517,352
+5.3%
9.35%
-14.8%
Q1 2023$31,431,233
+29.2%
491,497
-1.9%
10.98%
+11.7%
Q4 2022$24,321,986
-16.6%
501,071
+21.4%
9.83%
-14.0%
Q3 2022$29,159,000
-4.1%
412,797
-3.7%
11.42%
-4.2%
Q2 2022$30,395,000
-2.1%
428,512
+10.5%
11.92%
+10.4%
Q1 2022$31,062,000
+27.0%
387,857
+44.8%
10.80%
+37.8%
Q4 2021$24,450,000
-23.8%
267,792
+7.2%
7.84%
-24.9%
Q3 2021$32,094,000
-16.8%
249,842
-1.2%
10.44%
-18.6%
Q2 2021$38,580,000
+15.0%
252,984
-20.3%
12.82%
+7.1%
Q1 2021$33,562,000
-4.1%
317,585
-28.1%
11.97%
-21.4%
Q4 2020$34,983,000
+4.8%
441,590
-25.2%
15.23%
-7.4%
Q3 2020$33,380,000
-2.7%
590,170
+5.9%
16.44%
-18.8%
Q2 2020$34,296,000
+77.8%
557,300
-6.8%
20.24%
+43.6%
Q1 2020$19,293,000
-8.9%
598,033
-0.7%
14.09%
-25.1%
Q4 2019$21,188,000
+40.5%
602,453
+3.1%
18.82%
+40.7%
Q3 2019$15,076,000
-16.6%
584,228
-2.9%
13.37%
-8.5%
Q2 2019$18,069,000
-46.5%
601,828
-39.9%
14.62%
-0.4%
Q1 2019$33,745,000
+122.0%
1,000,972
+110.2%
14.67%
+1.3%
Q4 2018$15,198,000476,28614.48%
Other shareholders
STAAR SURGICAL CO shareholders Q3 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 9,264,427$372,244,67733.10%
Anatole Investment Management Ltd 2,101,359$84,432,60514.26%
APEIRON CAPITAL Ltd 351,712$14,131,7889.46%
Defender Capital, LLC. 543,397$21,833,6917.90%
Yunqi Capital Ltd 196,700$7,903,4066.08%
Palo Alto Investors LP 1,374,822$55,240,3485.23%
Jackson Square Partners, LLC 2,085,428$83,792,4972.80%
E Fund Management Co., Ltd. 782,296$31,4332.39%
GENEVA CAPITAL MANAGEMENT LLC 953,978$38,330,8400.81%
SECTORAL ASSET MANAGEMENT INC 47,000$1,888,4600.37%
View complete list of STAAR SURGICAL CO shareholders